Apellis Pharmaceuticals (APLS) Exchange Rate Effect (2020 - 2025)
Apellis Pharmaceuticals filings provide 6 years of Exchange Rate Effect readings, the most recent being $184000.0 for Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect rose 119.07% year-over-year to $184000.0, compared with a TTM value of $1.2 million through Dec 2025, up 289.68%, and an annual FY2025 reading of $1.2 million, up 289.68% over the prior year.
- Exchange Rate Effect hit $184000.0 in Q4 2025 for Apellis Pharmaceuticals, up from $22000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $685000.0 in Q2 2025, with the low at -$1.6 million in Q1 2021.
- Median Exchange Rate Effect over the past 5 years was $15000.0 (2021), compared with a mean of -$88900.0.
- The sharpest move saw Exchange Rate Effect plummeted 959.87% in 2021, then surged 2237.5% in 2022.
- Year by year, Exchange Rate Effect stood at $8000.0 in 2021, then skyrocketed by 2237.5% to $187000.0 in 2022, then skyrocketed by 212.3% to $584000.0 in 2023, then plummeted by 265.24% to -$965000.0 in 2024, then surged by 119.07% to $184000.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods came in at $184000.0, $22000.0, and $685000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.